Operating Income (Loss) in USD of PLIANT THERAPEUTICS, INC. from Q2 2019 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Pliant Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and change rate from Q2 2019 to Q3 2025.
  • Pliant Therapeutics, Inc. Operating Income (Loss) for the quarter ending 30 Sep 2025 was -$28.3M, a 54.4% increase year-over-year.
  • Pliant Therapeutics, Inc. Operating Income (Loss) for the twelve months ending 30 Sep 2025 was -$186M, a 16.2% increase year-over-year.
  • Pliant Therapeutics, Inc. annual Operating Income (Loss) for 2024 was -$228M, a 24% decline from 2023.
  • Pliant Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$184M, a 44.8% decline from 2022.
  • Pliant Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$127M, a 30.4% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Change (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Change (%)

PLIANT THERAPEUTICS, INC. Quarterly Operating Income (Loss) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$186M -$28.3M +$33.7M +54.4% 01 Jul 2025 30 Sep 2025 10-Q 06 Nov 2025
Q2 2025 -$220M -$45.6M +$15M +24.8% 01 Apr 2025 30 Jun 2025 10-Q 07 Aug 2025
Q1 2025 -$235M -$58.9M -$6.54M -12.5% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025
Q4 2024 -$228M -$53.3M -$6.28M -13.4% 01 Oct 2024 31 Dec 2024 10-K 03 Mar 2025
Q3 2024 -$222M -$62M -$14.3M -30% 01 Jul 2024 30 Sep 2024 10-Q 06 Nov 2025
Q2 2024 -$208M -$60.6M -$13.3M -28.1% 01 Apr 2024 30 Jun 2024 10-Q 07 Aug 2025
Q1 2024 -$194M -$52.4M -$10.3M -24.5% 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025
Q4 2023 -$184M -$47M -$9.64M -25.8% 01 Oct 2023 31 Dec 2023 10-K 03 Mar 2025
Q3 2023 -$175M -$47.7M -$15.7M -49.3% 01 Jul 2023 30 Sep 2023 10-Q 07 Nov 2024
Q2 2023 -$159M -$47.3M -$17.7M -59.7% 01 Apr 2023 30 Jun 2023 10-Q 07 Aug 2024
Q1 2023 -$141M -$42.1M -$13.9M -49.2% 01 Jan 2023 31 Mar 2023 10-Q 06 May 2024
Q4 2022 -$127M -$37.4M -$12.8M -52% 01 Oct 2022 31 Dec 2022 10-K 03 Mar 2025
Q3 2022 -$114M -$31.9M -$4.83M -17.8% 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023
Q2 2022 -$110M -$29.6M -$6.74M -29.4% 01 Apr 2022 30 Jun 2022 10-Q 09 Aug 2023
Q1 2022 -$103M -$28.2M -$5.29M -23.1% 01 Jan 2022 31 Mar 2022 10-Q 09 May 2023
Q4 2021 -$97.5M -$24.6M -$5.58M -29.4% 01 Oct 2021 31 Dec 2021 10-K 27 Feb 2024
Q3 2021 -$92M -$27.1M -$10.5M -62.7% 01 Jul 2021 30 Sep 2021 10-Q 08 Nov 2022
Q2 2021 -$81.5M -$22.9M -$5.93M -34.9% 01 Apr 2021 30 Jun 2021 10-Q 08 Aug 2022
Q1 2021 -$75.6M -$22.9M -$33.9M -308% 01 Jan 2021 31 Mar 2021 10-Q 09 May 2022
Q4 2020 -$41.6M -$19M 01 Oct 2020 31 Dec 2020 10-K 01 Mar 2022
Q3 2020 -$16.7M -$3.3M -24.7% 01 Jul 2020 30 Sep 2020 10-Q 09 Nov 2021
Q2 2020 -$17M -$1.24M -7.85% 01 Apr 2020 30 Jun 2020 10-Q 09 Aug 2021
Q1 2020 $11M 01 Jan 2020 31 Mar 2020 10-Q 10 May 2021
Q3 2019 -$13.4M 01 Jul 2019 30 Sep 2019 10-Q 10 Nov 2020
Q2 2019 -$15.7M 01 Apr 2019 30 Jun 2019 10-Q 11 Aug 2020

PLIANT THERAPEUTICS, INC. Annual Operating Income (Loss) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$228M -$44.2M -24% 01 Jan 2024 31 Dec 2024 10-K 03 Mar 2025
2023 -$184M -$56.9M -44.8% 01 Jan 2023 31 Dec 2023 10-K 03 Mar 2025
2022 -$127M -$29.7M -30.4% 01 Jan 2022 31 Dec 2022 10-K 03 Mar 2025
2021 -$97.5M -$55.9M -134% 01 Jan 2021 31 Dec 2021 10-K 27 Feb 2024
2020 -$41.6M -$40.4M -3283% 01 Jan 2020 31 Dec 2020 10-K 01 Mar 2022
2019 -$1.23M 01 Jan 2019 31 Dec 2019 10-K 01 Mar 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.